-
1
A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patientsResearch in context
Published 2025-02-01Subjects: “…Teprotumumab…”
Get full text
Article